Tirzepatide access
Gala vs Start Willow: Which One Offers Tirzepatide? (2026)
Gala or Start Willow? Side-by-side 2026 pricing, medication and service comparison, extended to six and twelve-month totals.
Published · Pricing as published in our provider dataset, synced · Editorial scores 7.7 and 7.3 out of 10
We may receive compensation when you click partner links. Rankings are based on research methodology, not sponsorship.
Put Gala and Start Willow side by side and the marketing reads almost identically. The programs underneath do not.
Molecule availability is the fork here: Start Willow covers both semaglutide and tirzepatide, while Gala publishes semaglutide alone. That matters most to anyone who may want to switch rather than simply escalate.
Below, the two programs are set against the things that change the bill — the advertised rate, the rate after the promotion expires, the medication class and the inclusions. Every figure traces back to the provider's own published material, and the missing ones stay missing.
The short answer
- Lowest 12-month cost
- Gala — $2,148 against $3,538 at Start Willow, on each provider's own best published pricing.
- Most support for the money
- Gala — Provider check-ins and dose monitoring included.
- Tirzepatide access
- Start Willow — The only one of the two that publishes a dual GIP/GLP-1 option.
- Easiest to pay for
- Gala — Neither publishes financing; both expect the full amount monthly.
Side-by-side comparison
This is the whole comparison in one screen. The sections underneath explain which of these rows should decide it.
| Gala | Start Willow | |
|---|---|---|
| Advertised price | From $249/mo, as low as $179/mo on longer plans | From $249 the first month, then $299/mo |
| Rate after promotions | $249/mo | $299/mo |
| Pricing structure | Cheaper per month the longer you commit | Promotional first month, then standard rate |
| Medication | Compounded semaglutide and compounded tirzepatide | Compounded semaglutide and compounded tirzepatide |
| Tirzepatide | Not published | Available |
| Price transparency | Published upfront | Published upfront |
| Support model | Provider check-ins included | No coaching program stated |
| Shipping | Home delivery | Delivery guaranteed in 3 days or less |
| Payment options | Card only, no financing published | Card only, no financing published |
| Patient reviews | 2,870 | 6,385 |
| eRxDoctor score | 7.7/10 | 7.3/10 |
The real cost: six months and twelve
The cheapest first month and the cheapest year are frequently different providers. The figures underneath convert both offers into what you will have spent by month six and month twelve.
| Gala | Start Willow | |
|---|---|---|
| First month | $249 | $249 |
| Months 2 onward | $249/mo | $299/mo |
| 6-month total | $1,494 | $1,744 |
| 12-month total | $2,988 | $3,538 |
| Best published plan | longer-term plan at $179/mo — $2,148/yr | No multi-month discount published |
Gala finishes the year $1,390 cheaper. For some patients the support Start Willow bundles closes that gap; for a patient who only needs the prescription written, it does not.
Price escalation to plan for: Start Willow moves from $249 to $299, a 20% increase. Set a calendar reminder for the month it changes.
Semaglutide, tirzepatide, and having somewhere to go next
Semaglutide is a GLP-1 receptor agonist. Tirzepatide adds GIP activity, and in head-to-head trial data it has produced larger average weight reductions. That does not make it the right first choice for everyone — it is typically more expensive and the side-effect profile is its own conversation — but it is the usual next step when semaglutide underdelivers.
Start Willow publishes both. Gala publishes compounded semaglutide and compounded tirzepatide, so switching molecules would mean switching provider, repeating an intake and losing whatever pricing you had locked in.
The question to ask yourself is not which molecule you want now, but how much friction a change would create later.
A closer look at Gala
Gala positions itself on a direct-pay model with dose monitoring included rather than sold as an add-on. Gala GLP-1 is a direct-pay telehealth platform offering compounded semaglutide and tirzepatide with provider check-ins and home delivery.
You start with fully online, no in-office visits; medication arrives via home delivery. The price behaves as cheaper per month the longer you commit.
On the clinical side, provider check-ins and dose monitoring included, prescribing compounded semaglutide and compounded tirzepatide.
Gala pros
- Direct-pay model, no insurance or prior authorizations needed
- Provider check-ins and dose monitoring included
- Fully online, no in-office visits required
Gala cons
- Lower long-term pricing requires a multi-month commitment
- Higher entry price than several compounded competitors
Against Start Willow specifically, the trade you are making: the entry price sits above most compounded competitors unless you commit to a longer term.
Inside the Start Willow program
From $249 per Month Against Gala, that puts it in the position of the more expensive option.
The process is fully online, no in-person visits, then delivery guaranteed in 3 days or less. On money, expect promotional first month, then standard rate — published upfront.
Behind the prescription sits direct-pay model that bypasses insurance pre-authorization. Available medication: compounded semaglutide and compounded tirzepatide.
Start Willow pros
- Fully online, no in-person visits or insurance forms
- Medications comparable to Ozempic and tirzepatide
- No insurance needed and no membership fees
- Direct-pay model bypasses insurance pre-authorization entirely
Start Willow cons
- Price rises from $249 first month to $299/month ongoing
- Ongoing $299/month is among the higher rates on this list
- Compounded medication only, no branded Ozempic or Wegovy
The cost of choosing this over Gala: at $299 ongoing it is among the most expensive compounded programs here.
Which one fits which patient
Choose Gala if:
- delivery works the way you want it to: home delivery
- you want to start on their timeline: fully online, no in-office visits
- the level of clinical contact suits you: provider check-ins and dose monitoring included
- you would get real value from a direct-pay model with dose monitoring included rather than sold as an add-on
Choose Start Willow if:
- delivery works the way you want it to: delivery guaranteed in 3 days or less
- what it leads on is worth paying for in your case: a delivery guarantee of three days or less and no membership stacked on the medication price
- you want tirzepatide available without changing provider later
- you want to start on their timeline: fully online, no in-person visits
Where each program concedes something
On price. Gala is the cheaper program at $249/mo against $299/mo. What Gala gives up for that is the entry price sits above most compounded competitors unless you commit to a longer term; what Start Willow charges for is a delivery guarantee of three days or less and no membership stacked on the medication price.
On clinical contact. Provider check-ins and dose monitoring included at Gala; direct-pay model that bypasses insurance pre-authorization at Start Willow. Neither is a substitute for in-person care if you have complicating conditions, and both bill you directly rather than your insurer.
On medication. Gala covers compounded semaglutide and compounded tirzepatide; Start Willow covers compounded semaglutide and compounded tirzepatide. Only Start Willow publishes a tirzepatide route, which matters if semaglutide underdelivers.
On access. Gala advertises fully online, no in-office visits and home delivery; Start Willow advertises fully online, no in-person visits and delivery guaranteed in 3 days or less. Neither publishes its state coverage, so confirm you are eligible before paying for anything.
Evidence and regulatory status
It is worth separating the program from the pharmacology. What follows is true of the medication regardless of which of these two writes the prescription.
Cardiovascular benefit has been demonstrated for semaglutide in a specific population: adults with overweight or obesity and existing cardiovascular disease but no diabetes, per NEJM, SELECT.
In SURMOUNT-4, stopping tirzepatide after a lead-in period produced significant weight regain, where staying on it did not, per JAMA, SURMOUNT-4.
Take the clinical questions to the prescribing clinician at whichever platform you choose; take the pricing questions to their support team before you pay.
Gala vs Start Willow: common questions
What happens when Start Willow's promotional price ends?
The rate moves to $299/mo, a 20% increase on the advertised entry price. Budget from that number rather than the headline, because it is the one you will pay for eleven of your first twelve months.
Is Gala cheaper than Start Willow?
Yes, on the ongoing rate. Gala runs $249/mo once promotional pricing ends, against $299/mo at Start Willow — a difference of 20%. Compare the first-month offers separately, because both providers discount entry differently from the rate you will actually be paying by month three.
Which costs less over a year, Gala or Start Willow?
Gala, at roughly $2,148 for twelve months against $3,538 at Start Willow, using each provider's own best published pricing. Those totals cover medication and program fees as published; they exclude anything a provider bills separately, and they assume you stay on the same plan for the full year.
Which has more patient reviews, Gala or Start Willow?
Start Willow, with 6,385 against 2,870. Ratings across this market cluster tightly, so volume is the more useful signal: it indicates how much operational load the platform has already absorbed, not how good the medication is.
Do Gala or Start Willow take insurance?
Both run on a direct-pay basis: you pay the platform and it does not bill your insurer. Neither publishes HSA/FSA acceptance, so budget the full amount as out-of-pocket spending.
Do Gala and Start Willow prescribe the same medication?
Both dispense compounded GLP-1 preparations. Gala lists compounded semaglutide and compounded tirzepatide and Start Willow lists compounded semaglutide and compounded tirzepatide, so the molecules overlap even where the formulary does not match exactly.
Does Gala or Start Willow offer tirzepatide?
Start Willow does. Gala publishes compounded semaglutide and compounded tirzepatide only, so moving to tirzepatide would mean moving provider — a new intake, a new price, and the loss of any rate you had locked in.
The verdict
Strictly on cost, Gala takes it — $2,148 to $3,538 over twelve months.
The case for Start Willow is a delivery guarantee of three days or less and no membership stacked on the medication price. That is worth $116 a month to some patients and nothing at all to others — be honest about which you are.
Whichever way you go, the medication is the same class of drug and the clinical questions belong to a clinician. What you are choosing here is a billing model and a support structure.
Keep comparing
- Gala vs EmbodyBudget vs premium
- Gala vs RefillsBudget vs premium
- JoinFridays vs Start WillowPublished price vs quote-only
- altRx vs Start WillowBudget vs premium
- Elevate Health vs MaximusTirzepatide access
- Elevate Health vs TMatesTirzepatide access
See every provider in context on the weight loss rankings, or browse the full comparison index.
Disclaimers and methodology
Medical content is informational only and does not replace professional diagnosis, treatment, or emergency care.
Some links are affiliate links and may generate commission at no extra cost to you.
Pricing reflects what each provider published as of the sync date above and changes frequently; confirm the current rate, and the rate at your maintenance dose, before you pay. Six- and twelve-month totals are calculated from those published rates and exclude anything a provider bills separately.
eRxDoctor is an independent publisher. It is not a medical provider, is not affiliated with or endorsed by Gala or Start Willow, and does not sell treatment. Read our ranking methodology.